Inventor

KLINDER KLAUS

DE20 patents

⚠️ This page may combine multiple inventors who share the name “KLINDER KLAUS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

KLINDER KLAUS

POUZET PASCALE

Piperazinodihydrothienopyrimidine derivatives

Substituted piperazino-dihydrothienopyrimidines

Heterocycle-substituted piperazino-dihydrothienopyrimidines

Heterocycle-substituted piperazino-dihydrothienopyrimidines

Piperazino-dihydrothienopyrimidine derivatives

BOEHRINGER INGELHEIM INT

Statine derivatives for the treatment of Alzheimer&#39;s disease III

2-[thiophen-2-yl)formamido]-N-(phenyl)-2-methylpropanamide derivatives and the use thereof as medicament

Method of treating diseases and conditions associated with an altered level of amyloid β peptides and new enolcarboxamide compounds

Method of treating diseases and conditions associated with an altered level of amyloid beta peptides and new enolcarboxamide compounds

Substituted 1,2-ethylenediamines, methods for preparing them and uses thereof

PFAU ROLAND

1H-benzimidazole-5-carboxamides as anti-inflammatory agents

1H-benz imidazole-5-carboxamides as anti-inflammatory agents

3H-imidazo [4, 5-B] pyridine-6-carboxamides as anti-inflammatory agents

3H-imidazo [4, 5-C] pyridine-6-carboxamides as anti-inflammatory agents

Compounds

BOEHRINGER INGELHEIM PHARMA

Trisubstituted pyrimidines

Positive allosteric AMPA receptor modulators (PAARM), processes for preparing them, and their use as pharmaceutical compositions

Anellated dihydropyridines for the treatment of chronic pain

FUCHS KLAUS

Substituted amino-benzimidazoles, medicaments comprimising said compound, their use and their method of manufacture

BOEHRINGER INGELHEIM VETMED

Method of treating diseases and conditions associated with an altered level of amyloid β peptides and new enolcarboxamide compounds

Statine derivatives for the treatment of Alzheimer's disease III